Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

Deal Watch March 2017

Sanofi, MedImmune, AstraZeneca, Astellas, Novartis and more feature in this month's pharma deals round-up

Roche Basel Switzerland

Roche’s Alecensa beats Xalkori as first-line lung cancer therapy

Data shows ALK inhibitor reduces risk of disease worsening

- PMLiVE

FDA won’t add outcomes data to Januvia label

Merck & Co’s application rejected despite TECOS outcomes data

Blending medical and digital for effective rare disease campaigns

The fundamentals of building a collaborative medical and digital team

- PMLiVE

Ironwood Pharmaceuticals appoints chief development officer

Dr Christopher Wright joins from Axcella Health

e-Therapeutics appoints new CEO

Dr Raymond Barlow joins firm from Amgen

- PMLiVE

Wilmington Healthcare launches STP website

Will provide pharma with information on the key NHS change

- PMLiVE

FDA changes its mind on 23andMe’s genetic testing kits

Approves a home test kit for gene sequences related to diseases like Alzheimer’s and Parkinson’s

- PMLiVE

Allergan pushes on with Botox for depression

Decision comes despite less than stellar clincial data

- PMLiVE

Dr Engelbert Tjeenk Willink joins Allecra Therapeutics

The French pharma company has also appointed Dr Leon Hooftman

- PMLiVE

Sanofi appoints Bill Sibold to lead its Genzyme business

He will succeed David Meeker, who is leaving in the firm in June

- PMLiVE

Focus on value: A prescription for pharma

The pricing debate demands a common language to be developed

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links